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The atomic structure of the DNA-containing T = 1 particle of the parvovirus minute virus of mice (MVM) reveals cylindrical projections
at each fivefold symmetry axis, each containing an 8 A˚ pore through which runs 10 amino acids of a single VP2 N-terminus. The tightest
constriction of this pore is formed at its inner end by the juxtaposition of leucine side chains from position 172 of five independent VP2
molecules. To test whether L172 modulates the extrusion of VP N-termini, we constructed and analyzed a complete set of amino acid
substitution mutants at this highly conserved residue. All but one mutant produced DNA-containing virions, but only two, L172V and
L172I, were infectious, the others being blocked for viral entry. Several mutants were significantly defective for assembly at 39 jC, but not
at 32 jC. L172W significantly impaired genome encapsidation, indicating that the fivefold cylinder may also be the DNA packaging portal.
Although tryptic cleavage of the VP2 N-terminus was not affected for the mutants, VP1 was degraded during proteolysis of mutant, but not
wild-type, virions.
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It is becoming increasingly apparent that the protein shell
of the viral capsid functions not only to protect the viral
genome from the outside world, but also carries signals that
catalyze the orderly intracellular trafficking of the virion
during entry, and in some cases, during egress. A prime
example of such a trafficking machine is the parvoviral
virion. The parvovirus capsid packages small, approximate-
ly 5 kilobase, genomes of single-stranded linear DNA. Their
limited coding capacity dictates that multiple activities must
reside within individual proteins or be expressed through
alternate reading frames. Unlike many larger viruses, the
parvoviruses do not carry into the cell accessory proteins
that assist in the entry process. Therefore, the virion poly-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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its own trafficking through intracellular compartments,
eventually delivering its genome into the nucleus for repli-
cation. The capsid of the minute virus of mice (MVM) is
assembled with a T = 1 icosahedral symmetry (Fig. 1A)
having a maximum external radius of 140 A˚ (Agbandje-
McKenna et al., 1998; Llamas-Saiz, 1997). The particle is
constructed from 60 subunits, comprising three viral pro-
teins, VP1, VP2, and VP3 (Tattersall et al., 1976). The
capsid proteins VP1 and VP2 are encoded from a single
viral gene through alternate splicing (Cotmore and Tatter-
sall, 1987). VP2 is the major structural protein, although
VP1, a 142 amino acid N-terminal extension of VP2, is
present in about 10 copies per virion (Tattersall et al., 1976).
The VP3 protein is produced through the proteolytic cleav-
age of approximately 25 amino acids from the N-terminus
of VP2 (Clinton and Hayashi, 1976; Tattersall et al., 1977).
The atomic structures of several parvoviruses, including
MVM, have been solved (Agbandje-McKenna et al., 1998;
Llamas-Saiz, 1997; Simpson et al., 1998, 2002; Tsao et al.,
1991; Xie et al., 2002). The core domain of each protein
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common to many viral capsid proteins (Rossmann and
Johnson, 1989). For MVM, the 547 amino acids common
to the C-terminus of each capsid protein are visible in the
crystal structure, as well as about a third of the viral DNA, but
the model gives no information about the disposition of the
individual N-termini of the proteins making up the shell.
On the outer surface of the capsid, at each of the 12
fivefold symmetry axes, are cylindrical projections encircled
by 15 A˚ canyons (Fig. 1A). These cylinders are constructed
from five juxtaposed antiparallel h-ribbons from each of theFig. 1.
Fig. 2.corresponding fivefold related capsid proteins. At the center
of each cylinder is a small pore with aminimal diameter of 8 A˚
that runs from the outer surface of the capsid to the inner core.
Weak electron density was observed within this channel in
DNA-containing, or full, virions, but not in empty particles,
and a glycine-rich region (VP2 residues G28-G-S-G-G-G-G-
S-G-G-G38) from a single VP protein (Fig. 1B) could be
modeled into this density (Agbandje-McKenna et al., 1998;
Tsao et al., 1991; Xie and Chapman, 1996). After G28, the
density becomes disordered, therefore making it impossible
to determine, from the crystal structure, whether VP1, VP2,
VP3, or a random assortment of VP N-termini are extruded
through the fivefold pores. At the base of each fivefold
cylinder, the remaining four VP proteins appear to fold back
into the interior of the particle at residues G36-G-G38
(Agbandje-McKenna et al., 1998; Llamas-Saiz, 1997).
Analysis of metabolically labeled particles demonstrated
that the VP2 N-terminus is accessible to antibodies in full
but not in empty capsids (Cotmore et al., 1999). The VP1 N-
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virion, although it can be exposed along with a simultaneous
extrusion of the 3Vend of the genome by heating virions in
excess of 52 jC (Cotmore et al., 1999). In addition to
antibody accessibility, VP2 to VP3 cleavage can be mim-
icked in vitro by incubation of virions with trypsin (Cotmore
et al., 1999; Tattersall et al., 1977; Weichert et al., 1998).
Although VP1 contains the same proteolytic site as VP2, it
is not accessible to trypsin digestion (Tattersall et al., 1977).
Exposure of the VP2 N-terminus to antibodies, the ability to
cleave VP2 to VP3 with trypsin, and the sequestration of
VP1 within the capsid suggest that VP2 is the resident
protein occupying the fivefold pore.
Mutagenic analysis of phosphorylated serine residues
within the VP2 N-terminus has shown that they are involved
in a late stage of the viral life cycle. It has been speculated
that they may function in viral egress from the nucleus
possibly in conjunction with NS2 (Maroto et al., 2000;
Miller and Pintel, 2002). Because the VP2 N-termini are
only exposed in packaged virions, their phosphorylation
may function to selectively signal for the export of virus
from the nucleus upon packaging.
Once released from the cell, particles consist of pre-
dominantly VP1 and VP2. Either in the extracellular
milieu or during reentry of the virus into host cells the
VP2 N-termini are cleaved yielding VP3. It is unclear as
to whether the VP2 to VP3 cleavage event is essential for
particle infectivity, because it has not yet been possible to
specifically prevent this cleavage from happening during
viral entry in vivo. However, if the VP2 N-termini
function as nuclear export signals, then their removal
might increase the efficiency of viral uptake into the
nucleus. The ‘‘snapshot’’ of the capsid derived from the
crystal structure predicts that only about one in four VP2
N-termini could be externalized through the fivefold poresFig. 1. The structure of MVM and conservation of L172 at the base of the fiv
(Agbandje-McKenna et al., 1998) centered on one of the twelve fivefold symmetr
application from a pentamer model constructed in Swiss PDB Viewer. This depicts
stick format, with the L172 residues at the base of each cylinder shown in space-f
with glycines in white and serines in gray. (C) Alignment of the capsid cylinder reg
of each genus of the Parvovirinae subfamily were aligned online using the MULTA
et al., 2000). Genera represented are 1–10, Parvovirus; 11–12, Bocavirus; 13, A
VP2 containing the antiparallel h-strands that comprise the fivefold cylinder, as d
1MVM, 1C8F and 1LP3, respectively) is shown highlighted in gray, while the c
lettering indicates similarity or identity across all five genera, blue lettering simila
*Residues lining the inner surface of the cylinder. +Residues with side-chains that
each of the VP proteins that comprise the fivefold cylinder and G36 of the VP2 N
highlight the level of constraint placed on the VP2 N-terminus by this residue an
Fig. 2. Only branched chain aliphatic residues are tolerated at position 172. iD5 ce
post-transfection, cultures were supplemented with medium containing either 1
transfection, cells were fixed and stained with DAPI and a monoclonal antibod
cultured in the presence (+Ab) or absence (Ab) of neutralizing antiserum. The
DAPI fields are shown below. (B) Representative fields of cells transfected with
expression. (C) Histogram of expansion indices determined for wild type and ea
infected cells observed, at 72 h, in the absence of neutralizing antibody by the num
counted for each experiment, which was repeated 3.at any one time. Trypsin digestion analysis of labeled
virions, however, has determined that greater than 90% of
the VP2 N-termini can be cleaved to the corresponding
VP3 molecules in vitro (Tattersall et al., 1977; Weichert et
al., 1998). These apparently contradictory results can be
reconciled if a mechanism exists to exchange each newly
formed VP3 molecule with an intact VP2, or if the
fivefold pore can expand during digestion allowing most,
if not all, of the VP2 N-termini to be accessed simulta-
neously by protease.
Unlike VP2, VP1 is dispensable for both assembly and
DNA packaging, but it is required for the production of
an infectious virion (Tullis et al., 1993). Antibodies
specific to VP1 have been shown to block infection when
microinjected into the cytoplasm indicating that although
initially internal, VP1 becomes exposed before nuclear
entry of the virus (Vihinen-Ranta et al., 2002). The VP1-
specific region contains both nuclear localization signals
(Lombardo et al., 2002; Vihinen-Ranta et al., 2002) and
an active phospholipase A2 (PLA2) enzymatic core
(Dorsch et al., 2002; Girod et al., 2002; Zadori et al.,
2001) that are essential for particle infectivity. Mutation of
PLA2 catalytic residues does not inhibit the accumulation
of virions in perinuclear compartments, apparently in late
endosomes/lysosomes, suggesting that this activity may be
required for viral escape from these compartments into the
cytosol.
The leucine residue at position 172 of VP2 forms the
tightest constriction within the fivefold pore. Alignments of
the antiparallel h-strands that comprise the fivefold cylinder,
as determined from the MVM, FPV, and AAV2 crystal
structures, demonstrate that the leucine in this position is
completely conserved across all genera of the Parvovirinae
subfamily, with the exception of the Erythroviruses (Fig.
1C). Interestingly, VP2 to VP3 cleavage does not occur inefold cylinder. (A) Depth-cued, space filling model of the MVMi capsid
y axes. (B) Cross-section of the fivefold channel, generated in the Pov-Ray
two of the five h-ribbons that comprise the cylinder, shown in red and green
illing format. Residues G28-G-S-G-G-G-G-S-G-G37 from VP2 are depicted
ion of all vertebrate parvoviral species. VP2 proteins from individual species
LIN program in the Network Protein Sequence Analysis package (Combet
mdovirus; 14–22, Dependovirus; and 23–27, Erythrovirus. The region of
etermined from the MVM, FPV, and AAV-2 crystal structures (PDB files:
onserved leucine (residue 172 in MVM) is underscored with yellow. Red
rity or identity across four genera, and green lettering identity across three.
project into the pore. (D) Tangential cross-section depicting L172 (wt) from
-terminus. Substitution of L172 with V, G, or W was modeled, as above, to
d the affect of mutations at the fivefold axis.
lls were transfected with wild-type or mutant infectious clones. Three hours
% neutralizing antibody or 1% prebleed serum. Seventy-two hours post-
y directed against the NS1 protein. (A) Wild-type transfected monolayers
top panels depict cells expressing the NS1 protein while the corresponding
L172 mutants, cultured in the absence of antibody, and stained for NS1
ch mutant. Expansion index was calculated by dividing the percentage of
ber observed in the presence. A minimum of 1500 DAPI stained cells were
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scopic studies of B19 particles have indicated that the
fivefold cylinder is closed (Agbandje et al., 1994; Chipman
et al., 1996). In addition, VP1 appears to be externalized on
mature B19 virions (Kawase et al., 1995), highlighting a
major difference between the Erythroviruses and those
belonging to the other parvoviral genera.
Amino acids disposed along the fivefold axis, such as
L172, have the unique property that equivalent residues
from each of the five subunits occupy adjacent regions of
space. Due to this close proximity, a distance of 8.6 A˚
between maximally opposed L172 side chains, any effect
of altering the size or charge of this amino acid would be
amplified fivefold. Indeed, molecular modeling of L172
within the MVM structure indicated that amino acid
substitutions at this residue could greatly affect the
constraints placed on the VP2 N-terminus that is exter-
nalized through the channel (Fig. 1D). It was therefore of
interest to ask whether L172 is involved in modulating
the flux of VP2 out of the capsid and the efficiency of its
cleavage to VP3. We also wished to investigate the
potential roles of the fivefold pore as the extrusion
channel for the VP1 N-terminus and in the process of
DNA packaging. As a first step in these studies, we have
generated a complete panel of amino acid substitutions
for position 172 and report here that mutations at this
residue not only affect viral entry but also capsid assem-
bly and DNA packaging.Results
Mutations at L172 disrupt virus spread through cell cultures
A complete amino acid substitution panel was con-
structed at position 172 of VP2 in the infectious clone of
MVMi, as described in Materials and methods. Immunoflu-
orescence (IF) expansion assays were used to screen
mutants for their ability to support multiple rounds of
infection. To standardize the assay, wild-type MVMi DNA
was transfected into iD5 cells, and 3 h later supplemented
with medium containing 1% of either rabbit anti-MVM
neutralizing antibody or prebleed serum. Cells were fixed
at either 24 or 72 h post-transfection and stained with a
mouse monoclonal antibody directed against the viral NS1
protein. At 24 h post-transfection, NS1 expression was
apparent in approximately 5% of cells, irrespective of
whether or not they were cultured in the presence of
neutralizing antibody (data not shown). After incubation
for a further 48 h only, 0.5% of the cells cultured in
neutralizing antibody remained positive for NS1, but 60%
of the cells in the control group were positive (Fig. 2A).
This f100-fold difference in the number of NS1 positive
cells at 72 h demonstrates that the neutralizing antibody
effectively inhibits secondary infections in this assay. In
addition, the 10-fold reduction observed between 24 and 72h in the test group suggests that 90% of the cells initially
transfected with DNA have died by 72 h.
In accord with the idea that L172 occupies a critical
position in the virus structure, the majority of mutations at
this residue resulted in a decrease in virus propagation. As
expected, the proportion of cells staining positive for NS1 at
24 h post-transfection was similar to wild type in either the
presence or absence of neutralizing antibody as was the
proportion of cells NS1 positive at 72 h in the presence of
antibody (data not shown). However, in the absence of
neutralizing antibody, only L172I and L172V showed sig-
nificant expansion, indicating that they were viable (Figs. 2B,
C). The remaining mutants, however, were significantly
impaired in their ability generate infectious virions upon
transfection. The levels of impairment for these mutants
ranged from 20-fold to over 100-fold relative to wild type
(Fig. 2C).
Alterations of size or charge at L172 results in a
temperature-sensitive assembly defect
Because the majority of substitutions at L172 disrupted
viral propagation, we next turned our attention to determin-
ing the specific point in the viral life cycle affected by each
mutation. Virus stocks were produced at 37 jC under
conditions that prevented second rounds of infection, as
described in Materials and methods, and capsid recovery
following transfection was analyzed using a hemagglutina-
tion assay (HA). Some mutant clones gave HA titers that
were between 5- and 12-fold lower than wild type, indicat-
ing that these substitutions likely affected capsid production
(data not shown).
To analyze this result further, capsid protein production
was assayed by IF to determine if the HA results were
due to defects in the expression of the capsid precursors
or in capsid assembly. Beginning immediately after trans-
fection, cultures were incubated at either 32 jC for 42
h or 39 jC for 36 h to monitor for any temperature-
sensitive effects. The efficiency of capsid assembly was
assayed by staining cells with a rabbit polyclonal anti-
body directed against heat denatured particles, which
primarily detects unassembled capsid precursors, and a
mouse monoclonal antibody cocktail that specifically
detects structural epitopes present within the assembled
particle (Cotmore et al., 1997, 1999). Structural protein
expression was readily detected for all mutants at both
temperatures (Figs. 3A, top panels, and C, and data not
shown).
At 32 jC, assembled particles could be detected in
approximately 90% of cells successfully transfected with
wild-type genomes (Fig. 3A), and the majority of mutants
were indistinguishable from wild type in this respect (Fig.
3B, dark bars). L172G showed the most severe assembly
defect at this temperature, generating only 80% of the
number of double positive cells observed with wild type
(Fig. 3B, dark bars). When grown at 39 jC, wild-type
Fig. 3. L172 mutation results in a temperature-sensitive assembly defect. Cells were transfected with wild-type or mutant clones and incubated for 42 h at 32 jC
or for 36 h at 39 jC before fixation. (A) Representative fields for wild-type and L172R transfected cells are shown for cultures grown at both 32 and 39 jC.
Capsid precursors were detected by indirect immunofluorescence with antibody directed against denatured particles (~-VP panels). Assembled particles were
detected using an anticapsid monoclonal mixture (~-cap panels). (B) Histogram of assembly indices (percentage of cells expressing capsid precursors
costaining for assembled particles). Values for each mutant were normalized to wild type. Data obtained from transfection at 32 jC are shown in gray, while
data obtained from 39 jC incubation are shown in white. Each data point represents a minimum of 100 a-VP positive cells and each experiment was repeated
in triplicate. (C) Nuclear localization of capsid precursors determined for wild type and representative mutants after growth at 39 jC. Samples were transfected
and stained for unassembled VP proteins as described above.
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than at 32 jC, indicating that wild-type virus itself is
somewhat temperature sensitive for assembly (Fig. 3A). A
continuum of temperature sensitivity was detected for
L172 mutants at the higher temperature. Aliphatic residues
appeared to give an increase in temperature sensitivity that
was inversely proportional to their size, so that L172G,
which showed a fivefold reduction in assembly compared
to wild type, was the most defective aliphatic substitution.
The opposite effect was observed for aromatic residues
with tryptophan exerting the greatest negative effect on
assembly, yielding only 1.5% of the double positive cells
observed for wild type. Charged amino acids also induced
temperature-sensitive assembly. Acidic residues were less
disruptive than the basic residues, with L172D assembling
to 20% of wild-type levels while L172R assembled 10-
fold less efficiently than L172D. Mutation of L172
appears to have no effect on the nuclear localization of
unassembled precursors at 39 jC (Fig. 3C), implying that
it is the building of the capsid quaternary structure, rather
than the trafficking of its subunits, that is impaired at this
temperature.Capsids assembled at 32 jC are stable at 39 jC
From the above screen, several mutations were found to
yield temperature-sensitive assembly defects, yet all
mutants assembled when grown at 32 jC. We selected
the most temperature-sensitive mutant from each of the
aliphatic, aromatic, acidic, and basic amino acid substitu-
tion groups, namely L172G, W, D, and R, and tested
whether their capsids were stable at the nonpermissive
temperature after assembly at 32 jC. Initially, we
employed the IF assay described above to analyze stability.
After transfection and incubation at 32 jC for 42 h,
samples were either transferred to 39 jC for 1 h or
maintained at 32 jC. No significant decrease in the
percentage of cells containing assembled capsids was
observed after the 1 h incubation at 39 jC (Figs. 4A,
B). The intensity of the capsid signal, however, diminished
slightly after incubation at 39 jC, although expression
levels of unassembled capsid polypeptides did not (Fig.
4A). Because these mutants should be blocked in assembly
when shifted to 39 jC, the decrease in intensity may be
attributed to the export of preformed particles from the
Fig. 4. Analysis of the stability of L172 mutants after assembly at the
permissive temperature. Cells were transfected with wild-type or mutant
clones and incubated for 42 h at 32 jC to allow for the accumulation of
assembled capsids. Cultures were subsequently maintained at 32 jC or
shifted to 39 jC for 1 h before fixation. (A) Representative fields of L172G
transfected cells after continuous incubation at 32 jC or incubation for 1 h at
39 jC. Top panels depict unassembled capsid expression (a-VP) while the
bottom panels show assembled capsids (a-cap), stained as in Fig. 3. (B)
Histogram of assembly indices for 32 jC and shifted cultures, determined
as in Fig. 3. The gray bars depict data collected from samples maintained at
32 jC throughout the experiment while data from samples incubated for
1 h at 39 jC are shown in white. (C) Particles of wild type, L172G, L172W,
L172D, and L172R were prepared from transfection at 32 jC and
subsequently incubated for 1 h at either 32 or 39 jC. Capsid titers for each
sample were determined by HA and the percentage of capsid recovered
after incubation at 39 jC is depicted in the histogram.
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differentiate between these two possibilities, we assayed
the hemagglutination activity of each of these L172 mutant
particles, produced at 32 jC, by incubation at either 32 or
39 jC for 1 h before assay. No significant difference in thelevel of assembled capsids was detected by this assay,
indicating that mutant particles are stable once assembled
(Fig. 4C).
Mutation of L172 to tryptophan drastically affects DNA
packaging
Parvovirus capsid assembly appears to proceed rapidly,
but the subsequent encapsidation of viral DNA is much
slower (Muller and Siegl, 1983; Myers and Carter, 1980;
Yuan and Parrish, 2001). Although relatively little is known
about the packaging process, the fact that the channel at the
fivefold symmetry axis connects the outer environment to
the interior of the particle makes the cylinder a prime
candidate for the DNA packaging portal. Cell extracts of
transfected cells grown at 32 jC were used to analyze DNA
packaging, so that packaging could be studied in the
absence of demonstrable assembly defects. The efficiency
of transfection was measured by HA and virus production
varied by only twofold between samples (data not shown).
To measure specifically the level of encapsidated DNA,
samples were treated with micrococcal nuclease before
electrophoresis through alkaline gels and analysis by south-
ern blot (Fig. 5A). The histogram depicts packaging effi-
ciency expressed as the level of protected DNA normalized
to the capsid concentration, detected in each sample by HA
(Fig. 5B).
Smaller aliphatic residues were found to reduce virion
production, with L172G packaging about twofold less DNA
than wild type. Mutants L172D and L172E were also
somewhat defective, indicating that a negative charge at
this position may hinder DNA packaging. The L172W
mutant was the most severely affected, showing a greater
than 10-fold reduction in packaged DNA relative to wild
type. To ensure that the packaging phenotypes observed
were not the result of inefficient DNA replication, plasmid
forms of each defective mutant were transfected, viral DNA
recovered by selective extraction (Hirt, 1967), DpnI
digested and analyzed by agarose gel electrophoresis fol-
lowed by Southern blot. Wild-type levels of replication
were observed for all of the mutants tested (data not shown).
We then investigated whether growth at 37 jC would
affect packaging efficiency because a temperature-sensitive
phenotype was observed for capsid assembly for many of
these mutants. The packaging efficiencies observed at 37 jC
were very similar to those determined at 32 jC for all
mutants although the relative amount of capsid production
varied (data not shown). This finding indicates that DNA
packaging is not significantly temperature sensitive, and that
this step does not account for the block in expansion
observed at 37 jC for most mutants. At both temperatures,
however, virion production was not detectable for L172W
indicating that an inability to encapsidate DNA is the
primary defect of this mutant. Although the ratio of packaged
DNA to HA titer was not altered between these two temper-
atures, the total level of packaged virions for wild type was
Fig. 5. Mutation of L172 to tryptophan affects DNA packaging. Extracts of transfected cells grown at 32 jC for 42 h were treated with micrococcal nuclease
before electrophoresis through alkaline gels and analysis by southern blot. (A) Analysis of packaging by Southern blot. Known amounts of 5-kb genomic
markers are depicted below the blot in nanograms (3–0.1), while the L172 mutants are shown in single letter code above (amb = L172amber; Ter = L172opal).
(B) Histogram of packaging indices for the mutants. Packaging index is the amount of viral DNA detected by Southern blotting normalized to the amount of
capsid present, as determined by HA, expressed as percent of wild type (dashed line). (C) Wild-type and L172W transfected cell extracts, normalized for HA,
were sedimented through 5–20% sucrose gradients, and fractions assayed for capsid by HA. The bottom panels show the results from electrophoresis of
individual fractions through alkaline gels and analysis by Southern blot.
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that full virion production is somewhat cold sensitive.
Because L172W is significantly temperature sensitive for
assembly, it could potentially misassemble at 32 jC. If this
was the case, DNA packaged into improperly assembledcapsids might not be protected from nuclease digestion,
resulting in the packaging defect observed in the above
assay. In order to analyze the defect in L172W packaging in
more detail, large-scale preparations of wild type and mutant
particles were extracted from transfected iD5 cells, concen-
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amounts of each stock were analyzed by sedimentation
through 5–20% sucrose gradients to separate full from
empty particles. Empty capsids were distributed similarly
throughout the wild type and L172W gradients, as a large
HA peak running through fractions 9–13 (Fig. 5C). Anal-
ysis of the fractions from the bottom of the gradients
revealed no distinct HA peak corresponding to DNA con-
taining particles for either wild type or L172W, indicating
that full virion production is quite inefficient following
transfection, even for the wild-type infectious clone. How-
ever, fractions 1–5 from wild type contained twofold to
eightfold greater HA compared to L172W fractions. South-
ern blot analysis of wild-type fractions after separation on
alkaline gels revealed two distinct species of DNA. A band
comigrating with 5 kb genomic DNA markers was found
predominantly in fractions 5 and 6, although a slower
mobility band sedimented in fractions 1 through 5 (Fig.
5C). However, when samples were subjected to micrococcal
nuclease digestion before denaturation, only the DNA in the
5 kb band was protected (data not shown). At present, we do
not know the origin of the lower mobility band, but clearly,
when L172W fractions were analyzed in the same way,
neither DNA band could be detected in this region of the
gradient, indicating that packaged virions were not pro-
duced. Because L172W elaborates empty particles indistin-
guishable from those of wild type on velocity gradients,
apparently the block in DNA packaging of this mutant is not
due to its inability to properly assemble the capsid shell.Fig. 6. Mutation of L172 disrupts virion infectivity. (A) iD5 monolayers were infe
and fixed 24 h postinfection. Panels depict representative fields of infected cells s
(B) Histogram showing infectivity indices for the mutants. The infectivity index
staining cells) normalized to that obtained with wild type.Mutation of L172 alters particle infectivity
Although the initial expansion assay showed that the
viability of each L172 substitution mutant was impaired,
only the L172W mutation significantly reduced the number
of packaged virions generated from transfection. This
suggests that the primary defect in the L172 mutants lies
in their inability to establish a second round of infection.
In order to establish that this was indeed the case, infection
of cells with purified mutant virions was assayed by
immunofluorescence at 24 h postinfection, using antibodies
generated against the NS1 protein. In the assay shown in
Figs. 6A and B, wild-type virus infected 19% of the cells,
although L172I and L172V gave only slightly lower
figures. The remaining mutants were severely impaired,
giving infectivity levels that ranged from an approximately
13-fold reduction for L172C to a more than 700-fold
reduction for L172R. These results were very similar to
those observed in the expansion assay, indicating that the
most common defect resulting from mutation at residue
L172 was a severe block in one or more early steps of
infection.
The disposition of the VP N-termini is similar in wild-type
and L172 mutant virions
Both crystallographic and biochemical evidence sug-
gests that the N-termini of VP2 molecules project to the
outside of the particle through the fivefold cylinder. To askcted with 30000 genome equivalents of wild-type or mutant virions per cell
tained with a mouse monoclonal antibody directed against the NS1 protein.
was determined as the percentage of NS1 positive cells (relative to DAPI
Fig. 7. Analysis of metabolically labeled virions. (A) Purified, 35S-labeled
wild-type and mutant virions were immunoprecipitated with antibodies
against the assembled capsid, the VP2 N-terminus or the VP1-specific
region. Sequentially immunoprecipitated samples were first precipitated
with anti-VP1 antibodies and then with anticapsid antibodies. (B) VP2
cleavage analysis of samples incubated with trypsin for 0–30 min before
electrophoresis. For the t = 0 samples, trypsin was inactivated with PMSF
and EDTA before addition of the virus, while in the negative trypsin lanes,
samples were incubated for 30 min at 37 jC in sample buffer alone. (C)
Samples were incubated in the presence or absence of a 30-fold excess of
trypsin for 1 h at 37 jC. (D) VP1 exposure induced by heating virions in
vitro. Virus samples were heated for 10 min at the temperature indicated
above each lane before the addition of antiserum.
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attempted to metabolically label virus generated by the
transfection of asynchronous iD5 cultures; however, only
trace amounts of labeled virions were obtained. To bypass
the inefficiencies of labeling following transfection, we
utilized an MVM trans-encapsidation system that was
developed for the production of parvoviral vaccine vectors
(Palmer and Tattersall, 2000; Palmer et al., 2004). By
cotransfecting cells with an L172 mutant infectious clone
plasmid and a plasmid expressing the wild-type capsid
gene, we were able to pseudotype L172 mutant genomes
into hybrid capsids that were predominantly wild type in
origin. These trans-encapsidated virus stocks were found
to support a single round of infection, whose progeny
retained their initial defective phenotypes in the second
round of infection, indicating that recombination between
plasmids or reversion of the mutation at position 172 was
minimal (data not shown).
In order to analyze the disposition of the VP N-termini,
we first prepared such pseudotyped virus stocks of L172F,
L172G, and L172T, as well as a wild-type control. These
virions were used to infect synchronized iD5 cells from
which metabolically labeled virions were then produced,
and purified on iodixanol step gradients as described in
Materials and methods. Previous studies with metabolically
labeled virions of the fibrotropic strain MVMp had dem-
onstrated that serum directed against the N-terminal 25
residues of VP2 could immunoprecipitate all virions,
although serum directed against the entire VP1-specific
region precipitated very few (Cotmore et al., 1999). As
expected, wild-type MVMi virions were quantitatively
precipitated with this VP2 N-terminus-specific serum
(Fig. 7A). VP1-specific serum failed to precipitate wild-
type MVMi, but these virions could be subsequently
precipitated from this sample with anticapsid serum, indi-
cating that this virus was intact and that VP1 was inter-
nalized, as reported for wild-type MVMp (Cotmore et al.,
1999). Similar results were obtained with each of the three
L172 mutant viruses tested, indicating that the VP N-
termini were properly disposed in these assembled, pack-
aged virions (Fig. 7A, panels G, T, and F), despite their
inability to initiate infection.
The flux of VP1, but not that of VP2, N-termini is affected by
mutation of L172
We initially hypothesized that L172 might regulate the
flux of VP2 N-termini through the pore and thereby
control the VP2 to VP3 cleavage event. This idea was
based on many factors, including the conservation of L172
within the vertebrate parvoviruses and the constraints that
L172 places on the glycine-rich stretch of VP2 that has
been modeled into the pore of the fivefold cylinder. To
analyze the effects of the L172 mutations on VP2 to VP3
conversion, we digested wild type, L172T, L172F, and
L172G viruses with trypsin in vitro. Initially, VP2 was thepredominant capsid protein, accounting for between 80%
and 95% of the total VP2/VP3 protein (Fig. 7B, t = 0 and
trypsin lanes). However, VP2 was rapidly converted to
VP3 by trypsin, so that within 10 min, 50% of the VP2 in
the wild-type virus was converted to VP3. Cleavage rates
subsequently slowed, with 67% of VP2 converted by 30
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mutants, VP2 cleavage was most extensive for L172T,
where 73% of VP2 was cleaved after 30 min, while only
46% of L172F VP2 was cleaved in the same period (Fig.
7B, panels T, G, and F).
We next asked whether the slower cleavage rate ob-
served for L172F might translate to incomplete VP2 to
VP3 conversion, and so possibly account for the block to
entry observed for this mutant. After a 30 overdigestion
of wild type with trypsin for 1 h at 37 jC, the majority of
VP2 molecules were cleaved to VP3, while the fraction of
total structural protein that comprised VP1 remained con-
stant at 14% throughout the incubation, indicating that
particles remained essentially intact (Fig. 7C). The extent
of VP2 to VP3 conversion was similar between wild type
and each of the mutants; however, VP1 levels dropped
during digestion for each of the L172 mutants. L172T was
the most dramatically affected, with VP1 levels dropping
to less than 3% of total capsid protein during digestion,
while L172F and G both lost approximately half of their
original VP1 component (Fig. 7C). We have already
shown by immunoprecipitation that the VP1 N-termini of
these mutant viruses were sequestered within the virion
when incubated at 4 jC (Fig. 7A). Thus, the trypsin
digestions suggest that mutant particles must be intrinsi-
cally less stable than wild type. It is possible that they
either fall apart during prolonged incubation at 37 jC in
the presence of trypsin or else they undergo the confor-
mational transition discussed previously, leaving the N-
termini of their VP1 molecules exposed either transiently
or permanently at the surface of the otherwise-intact virion.
Because there was no evidence for significant VP2 degra-
dation in these analyses, the latter scenario seems the most
likely, so we then evaluated this transition in vitro for wild-
type MVMi and the same set of three representative mutant
viruses.
Heating wild-type MVMi between 40 and 50 jC
resulted in the exposure of VP1 in 13% of virions. This
increases to 20% after heating to 60 jC, and to 50% after
heating to 70 jC. Even at 70 jC, the MVMi virion
remains intact, as determined from the fraction of VP2
precipitated by a-VP1 antiserum, and by precipitation
with structure-specific antiserum (data not shown). L172
mutants displayed similar stability and transitioning phe-
notypes, with 60% of L172F or L172T precipitating after
heating to 70 jC, while L172G was slightly impaired for
transition, giving 40% precipitable when heated to the
same temperature (Fig. 7D, panels G, T, and F). These
results indicate that L172 mutant particles do not show
the altered VP1 transition event that we anticipated from
the in vitro trypsin experiments. However, because VP2
remains intact during these heating experiments, but not
during the digestion experiments, this suggests a possible
mechanism by which proteolysis may enhance VP1 ex-
trusion in the mutant virions, as will be discussed further
below.Discussion
Specific interactions at the fivefold axis appear necessary
for capsid assembly
Both biochemical and structural studies of the parvovi-
ruses has yielded a detailed description of the assembled
capsid. However, an understanding of the underlying pro-
cess of capsid assembly has remained elusive, due in part to
the transient nature of assembly intermediates. Studies on
CPV have demonstrated that small amounts of VP2, or
possibly VP2/VP1, trimer can be isolated from extracts of
cells transfected with wild-type genomes. Mutations that
disrupt the potential VP2 nuclear localization motif (K536T/
K538T) or that block assembly (V522G) abrogate trimer
formation (Yuan and Parrish, 2001). Immunofluorescence
analyses of transfected cells expressing these mutant CPV
structural proteins demonstrated that they were able to enter
the nucleus but were not retained there, as are those of wild
type, suggesting that capsid assembly per se is required for
nuclear accumulation. However, trimer formation, which
should not be affected by the 172 mutations, has been
implicated in the correct display of the nuclear localization
signal on MVM VP2 molecules (Lombardo et al., 2000).
We found that the temperature-sensitive assembly mutants
analyzed in this study accumulated VPs in the nucleus at the
nonpermissive temperature. This suggests that the assembly
of intact capsids is not essential for nuclear retention of VPs;
however, assembled particles appear to be stringently
retained in the nucleus upon assembly. Because the assem-
bled capsid has a molecular weight greater than 4 million, it
would require active transport through the nuclear pore to
enter the cytosol. Phosphorylation of serine residues at the
N-terminus of VP2 may act as a nuclear export signal for
packaged virions (Maroto et al., 2000) and might redirect
VP2 to the cytosol if capsid assembly was inhibited, as seen
for CPV. It is possible that trimerization enhances the
nuclear import signal, such that subsequent phosphorylation
of the VP2 N-termini is not sufficient to export these trimers
from the nucleus. We are currently testing whether L172
assembly mutants indeed form stable trimers at 39 jC, and if
so, whether these precursors assemble into capsids upon
shift down to the permissive temperature.
In vitro disassembly of empty CPV capsids has shown
that dimers, trimers, and pentamers are released by urea or
pH extremes, indicating that the fivefold interaction may
become stabilized upon assembly (Yuan and Parrish, 2001).
Our study suggests that this fivefold interaction is important
because several amino acid substitutions at this position
affected capsid assembly. It is easy to envision that the
addition of bulky or charged residues at this position might
sterically hinder contacts between fivefold related partners
essential for particle assembly, although we would not have
predicted that the L172G mutation would have such an
effect. It is possible that the spacing between adjacent capsid
subunits is maintained by L172 during the initial stages of
G.A. Farr, P. Tattersall / Virology 323 (2004) 243–256 253assembly around the fivefold axis. L172G mutation might
allow too close a juxtaposition of the VPs, interfering with
the formation of other important contacts around the five-
fold axis.
The fivefold cylinder may function as the portal for DNA
packaging
Parvovirus genomes replicate by rolling hairpin replica-
tion, a modified version of rolling circle replication. During
this process, concatemeric DNA arises, which must be
resolved by site-specific nicking to produce genome length
DNA (Cotmore and Tattersall, 2003). Preformed capsids
have been suggested to serve as packaging vehicles (King et
al., 2001; Myers and Carter, 1980; Zhou and Muzyczka,
1998); however, the portal for DNA packaging has
remained unresolved. In many bacteriophage systems and
for herpes simplex virus 1 (HSV-1), portal proteins are
found to interact with a single fivefold vertex and direct
the interaction of a packaging enzyme with the icosahedral
shell (Catalano et al., 1995; Hendrix, 1998). HSV-1, much
like MVM, must both resolve large concatemeric viral DNA
down to unit length genomes and package these molecules
into preformed capsids. Generally, portal proteins interact
with the capsid as a dodecameric ring and are found as an
integral part of mature capsids. Although such portal pro-
teins have not been identified for the parvoviruses, the small
Rep proteins of AAV-2, Rep52/40, appear to function as the
packaging motor for delivery of DNA into the capsid
(Chejanovsky and Carter, 1989; King et al., 2001). In
MVM, NS1 most likely allows both the association of the
DNAwith the capsid and functions as the packaging motor,
although no details of this process or the form of NS1 that
carries it out have been described. In this study, we have
demonstrated that mutation of L172W, an internal mutation
at the base of the fivefold cylinder, disrupts DNA packag-
ing. Unlike the majority of L172 mutations, which were
found to affect infectivity or assembly, only the substitution
of tryptophan at this position inhibited DNA packaging
significantly, suggesting that L172 does not play a direct
role in the packaging process. Because DNA packaging is
most likely an ATP-driven event, it is reasonable to con-
clude that a mutation would need to stringently obstruct the
pore to block the incoming DNA. From models of the
L172W cylinder, clearly five tryptophan residues would
significantly impede the passage of single-stranded DNA
even if the channel was able to expand during packaging.
Because the L172W mutation has also been shown to
yield defects in capsid assembly, instability of packaged
virions may play a part in the observed packaging defect.
Mutant capsids might dissociate during the act of packag-
ing; however, because empty capsids are the predominant
species present in wild-type-transfected cells, such a small
decrease in capsid levels due to packaging-induced dissoci-
ation would be difficult to detect. In order to address this
possibility, an in vitro packaging system would be required,where known amounts of wild-type or mutant capsids could
be monitored for stability during packaging.
Infectivity is impaired by mutation of L172 to any amino
acid
The infectious entry pathways for non-enveloped viruses
are less well understood compared to those of many
enveloped viruses. Parvoviruses are taken up by receptor-
mediated endocytosis, with MVM utilizing terminal sialic
acid moieties of an unknown cell surface protein(s) as
receptor (Cotmore and Tattersall, 1987). While it is known
that endosomal acidification is required for productive
infection (Bartlett et al., 2000; Basak and Turner, 1992;
Ros et al., 2002), it is not clear whether the VP2 to VP3
cleavage occurs before, after, or during this step. It is also
not known whether the VP2 to VP3 cleavage is essential for
infection, but it is thought that VP1 must be exposed
concurrent with, or before, particle entry into the cytosol.
We have shown here that any substitution at L172 impairs
infectivity, compared to wild type, at an early step in the
process of infection, and that this decrease ranges from
twofold, as observed for L172I to >700-fold as found for
L172R. Immunoprecipitation of virions produced under
conditions that minimize VP2 cleavage indicates that mutant
virus preparations are virtually identical to wild type upon
release from the cell. We initially hypothesized that L172
might regulate VP2 to VP3 cleavage and subsequent VP1
externalization, and that this might account for the block
observed during infection. Based on kinetic analysis of VP2
cleavage, however, wild type and most mutants appear to be
cleaved at similar rates, and although substitution of L172
with the bulky aromatic amino acid phenylalanine did
slightly impair VP2 cleavage, there was no absolute block
to this step when assayed under excess trypsin. It is possible
that VP2 cleavage must occur in a temporally controlled
manner, in conjunction with trafficking between specific
endocytic compartments. If this were the case, then the
small differences observed in the cleavage rates between
wild-type and mutant viruses might have a large impact on
the efficiency of virus infection. More likely, however, is
that the disappearance of intact VP1 observed during trypsin
digestion is responsible for the lack of particle infectivity. It
is conceivable that L172 mutants lose VP1 as they are
trafficked to late endosomes or lysosomes, where the VP2 to
VP3 cleavage may normally occur in vivo. The VP1-
specific region appears to be essential for its PLA2 activity
and nuclear localization motifs; therefore, the degradation of
VP1 before virion entry into the cytosol could account for
the lack of infectivity of these mutants. Surprisingly, anal-
ysis of the transition temperature indicated that L172
mutation does not directly affect the exposure of VP1.
However, these mutant particles contained predominantly
VP2, and recent studies in our laboratory indicate that prior
cleavage of VP2 to VP3 increases the efficiency and reduces
the transition temperature for VP1 extrusion (Cotmore, S.F.,
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might spontaneously transition under physiological condi-
tions, following VP2 to VP3 cleavage, while wild-type
particles remain stable. We are currently analyzing the early
steps of entry with L172 mutant particles in detail, by
following the localization of mutant virions relative to wild
type and determining whether VP1 degradation does indeed
occur during mutant virus entry.Materials and methods
Cell lines
Hyb1/11 iD5 cells (called iD5 throughout) are a sub-
clone of Hyb1/11, which was formed by the fusion of A9
ouabr11 cells with EL4 cells (Gardiner and Tattersall,
1988; Tattersall and Bratton, 1983), and are able to serve
as productive host cells for both the lymphotropic variant
MVMi and fibrotropic MVMp. CMT4 cells are trans-
formed monkey cell lines that inducibly express simian
virus 40 T antigen (Gerard and Gluzman, 1985). These
cells were utilized for large-scale production of L172
mutant and pseudotyped virus stocks due to their suscep-
tibility to Ca-PO4 transfection and the requirement of T
antigen for replication of the capsid expression plasmid.
CMT4 stocks were maintained in DMEM supplemented
with 10% fetal bovine serum.
Production of mutations at position 172 of the VP2 protein
Mutations at position 172 of the VP2 protein were
engineered by two-step PCR using the Expand High Fidelity
PCR System (Roche Diagnostics, Mannheim, Germany) to
prevent the accumulation of spontaneous point mutations.
Primers WF5, 5 V-T G G G T G A C G G C T GG G TA G-3 V,
and GF1 (containing either degeneracy or specific mutations
at position 172), 5V-C T G C A A C C AT C AT G C A A G C
T G N N N G T C AT T G T T G TATAT-3 V, generated the
upstream fragment while RM8 (which overlaps with the
5 Vregion of GF1), 5 V-G C AT G AT GG T T G CAG-3 V, and
WF3, 5 V-C AGCAGTGGAGGCTGTCC-3 Vgenerated
the downstream fragment. The overlapping PCR products
were then purified and subjected to a second round of PCR
generating the insert precursor fragment. This fragment
was introduced into the infectious clone plasmid of MVMi
between the unique SpeI and MfeI restriction sites flanking
residue 172, and their presence confirmed by DNA
sequencing.
Transfection of cells for immunofluorescence assays
Between 2000 and 4000, iD5 cells were seeded on
glass spots on Teflon-coated ‘‘spot-slides’’ (Cell-Line
Associates, Inc., Newfield, NJ) and incubated at 37 jC
for 18 h. Transfection of 200 ng/spot of infectious cloneDNA was accomplished using Superfectk transfection
reagent (Quiagen, Inc. Valencia, CA) at a 1:8 DNA to
superfect ratio. Cells were fixed with 2.5% paraformalde-
hyde at the indicated times. Staining of viral gene prod-
ucts was accomplished as previously described (Cotmore
and Tattersall, 1990). The polyclonal a-VP antibody was
raised in rabbits by repeated injection of SDS-denatured,
purified capsid protein, and the other antibodies were as
previously described (Cotmore et al., 1997, 1999). Prima-
ry antibodies were detected with Texas-Red conjugated
goat anti-mouse IgG or FITC conjugated goat anti-rabbit
IgG (Jackson ImmunoResearch Laboratories, Inc., West
Grove, PA). Color images were acquired using standard-
ized exposures on a Nikon OptiPhot epi-fluorescence
microscope fitted with a Kodak digital camera driven by
MDS 290 software. Multiple images were viewed and
quantitated, by single-blinded analysis, in Adobe Photo-
shop 6.0.
Production of viral stocks in a single round
iD5 cells (9.0  105) were seeded per 100-mm dish and
grown for 12–18 h at 37 jC. Fifteen micrograms of
infectious clone DNAwas transfected per plate using Super-
fectk and cells incubated for 2 h at 37 jC before washing
with PBS and supplementation with medium containing
Clostridium perfringens neuraminidase (Sigma Co., St.
Louis, MO) at 0.1 mg/ml. Neuraminidase destroys the
receptor used by MVM preventing released virus from
reentering cells (Cotmore and Tattersall, 1989). Cultures
were incubated for a total of 48 h post-transfection at either
32 or 37 jC. Virus was extracted from cells by 3 freeze/
thaw into 50 mM Tris–HCl, 0.5 mM EDTA, pH 8.7 (TE
8.7), and clarified by centrifugation at 15000  g for 10 min
at 4 jC. HA titers were determined by serial dilution in PBS
followed by incubation with 0.5% (final concentration)
guinea pig erythrocytes. Hemagglutination endpoints were
read after incubation at 4 jC overnight.
For large scale preparations, extracts were clarified by
centrifugation as above for 30 min, and concentrated using
Vivaspin 100000 molecular weight cut off concentrators
(Vivascience, Inc. Carlsbad, CA).
Detection of viral DNA for the packaging assay
TE 8.7 extract (1.8  105 cell equivalents) were digested
with micrococcal nuclease (0.4 Ag/Al) for 1.5 h at 32 jC
followed by proteinase K treatment (0.7 Ag/ml), sequentially
for 45 min at 32 jC and then for 45 min at 37 jC. Samples
were then incubated in 0.5% SDS for 15 min, exposed to
0.03 M NaOH, and analyzed on a 1.4% alkaline gel by
Southern blotting on to Zeta-Probe GT membrane (Bio-Rad
Laboratories, Hercules CA). DNA was cross-linked to the
membrane by UV irradiation and hybridization performed
with a random primed (Roche Diagnostics Gmb) MVM
DNA probe that detects the entire genome.
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Viral stocks were generated by transfection of 24  100-
mm dishes of CMT4 cells by CaPO4 precipitation as
previously described (Ball-Goodrich et al., 1991). Briefly,
9  105 cells were seeded per dish and incubated at 37 jC
over night. Fifteen micrograms of infectious clone DNA or
for trans-encapsidation, 15 Ag of a 2:1 mixture of wild-type
capsid expression plasmid and viral DNA (Palmer et al.,
2004) was transfected per dish and virus extracted at 72
h post-transfection by freezing and thawing in TE 8.7.
Clarified extracts were concentrated as above and virions
purified on 5–20% sucrose gradients. Purified virions were
analyzed by Southern blotting of alkaline agarose gels and
genomes quantified using a Phosphorimager. Semiconfluent
monolayers of iD5 cells on spot slides were infected at
30000 genome equivalents per cell for 3 h at 37 jC. The
cells were subsequently washed 3 with PBS and supple-
mented with medium containing neuraminidase. Cells were
fixed at 24 h post-transfection and stained with a mouse
monoclonal antibody against the NS1 protein.
Production and purification of metabolically labeled virions
iD5 cells were synchronized as previously described for
A9 fibroblasts with minor modifications (Tattersall and
Bratton, 1983). Briefly, pseudotyped virions were added
at 0.7 NS1 inducing units per cell simultaneously with 10
Ag/ml aphidicolin and cultured for 18 h before removal of
the inhibitor. Cells were labeled with EXPRE 35S–35S
protein labeling mix (NEN Life Science Products, Inc.,
Boston, MA) at 100 ACi/ml in DMEM containing 1/50th of
the normal concentration of unlabeled methionine and
cysteine. Label was added 4 h after release from aphidicolin
block and removed 8 h later to be replaced with medium
containing neuraminidase at 0.1 mg/ml. Medium containing
released virus was collected 18 h after the addition of label
and cleared by centrifugation at 15000  g for 30 min at
4 jC. Five milliliters of cleared supernatant was layered on
a 6 ml iodixanol (OptiPrep, Axis-Shield, Oslo, Norway)
step gradient (55%, 45%, 35%, and 15% + 1 M NaCl, all in
PBS and 1 mM MgCl2 and 2.5 mM KCl), and centrifuged
at 35000 rpm for 18 h at 18 jC in a Beckman SW41 rotor.
Fractions were collected from the bottom of the gradient
and full virions pooled for analysis.
Immunoprecipitation and trypsin digestion
Labeled virions were precipitated with anticapsid anti-
bodies as described by Li et al. (1994), with minor mod-
ifications. Samples were diluted 1:10 into RIPA buffer (10
mM Tris–HCl, 150 mM NaCl, 1% deoxycholate, 1% Triton
X-100, 0.1% SDS, pH 7.5) and incubated with antisera
recognizing assembled capsids, the VP2 N-terminus, or the
VP1 N-terminus (1:100 dilution) at 0 jC for 2 h. Complexes
were collected on formalin-fixed Staphylococcus aureus(Boehringer Mannheim, Mannheim, Germany) and washed
3 with 5% sucrose, 1% NP-40, 500 mM NaCl, 50 mM
Tris–HCl, 5 mM EDTA, pH 7.5, followed by a single wash
in RIPA buffer. Samples were boiled in SDS sample buffer
for 10 min and analyzed by electrophoresis through discon-
tinuous SDS polyacrylamide gels, containing 7.5% acryl-
amide, 0.2% bis-acrylamide (Laemmli, 1970), and
processed as described previously (Cotmore et al., 1999).
For the analysis of VP1 extrusion, purified virions were
diluted 1:20 in RIPA buffer containing 3 AM CaCl2 before
incubation at the specified temperatures for 10 min. Samples
were subsequently immunoprecipitated and analyzed by gel
electrophoresis as described above.
For trypsin digestion, virions were diluted into 50 mM
Tris–HCl, 50 mM NaCl, 0.25 mM DTT, and 2.5 AM CaCl,
pH 7.5. TPCK-trypsin (Cooper Biomedical) was added to
2 ng/Al final concentration and incubated at 37 jC for the
specified time. Trypsin was inactivated by incubation in 4.5
mM PMSF and 20 mM EDTA for 10 min at room
temperature before analysis by electrophoresis as described
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